These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33529230)

  • 1. High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector.
    Sinegubova MV; Orlova NA; Kovnir SV; Dayanova LK; Vorobiev II
    PLoS One; 2021; 16(2):e0242890. PubMed ID: 33529230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter from Chinese hamster elongation factor-1a gene and Epstein-Barr virus terminal repeats concatemer fragment maintain stable high-level expression of recombinant proteins.
    Sinegubova MV; Orlova NA; Vorobiev II
    PeerJ; 2023; 11():e16287. PubMed ID: 37901457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.
    Nyon MP; Du L; Tseng CK; Seid CA; Pollet J; Naceanceno KS; Agrawal A; Algaissi A; Peng BH; Tai W; Jiang S; Bottazzi ME; Strych U; Hotez PJ
    Vaccine; 2018 Mar; 36(14):1853-1862. PubMed ID: 29496347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells.
    Gstöttner C; Zhang T; Resemann A; Ruben S; Pengelley S; Suckau D; Welsink T; Wuhrer M; Domínguez-Vega E
    Anal Chem; 2021 May; 93(17):6839-6847. PubMed ID: 33871970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved elongation factor-1 alpha-based vectors for stable high-level expression of heterologous proteins in Chinese hamster ovary cells.
    Orlova NA; Kovnir SV; Hodak JA; Vorobiev II; Gabibov AG; Skryabin KG
    BMC Biotechnol; 2014 Jun; 14():56. PubMed ID: 24929670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene.
    Running Deer J; Allison DS
    Biotechnol Prog; 2004; 20(3):880-9. PubMed ID: 15176895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of trimeric SARS-CoV-2 spike protein by CHO cells for serological COVID-19 testing.
    Johari YB; Jaffé SRP; Scarrott JM; Johnson AO; Mozzanino T; Pohle TH; Maisuria S; Bhayat-Cammack A; Lambiase G; Brown AJ; Tee KL; Jackson PJ; Wong TS; Dickman MJ; Sargur RB; James DC
    Biotechnol Bioeng; 2021 Feb; 118(2):1013-1021. PubMed ID: 33128388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells.
    Stuible M; Gervais C; Lord-Dufour S; Perret S; L'Abbé D; Schrag J; St-Laurent G; Durocher Y
    J Biotechnol; 2021 Jan; 326():21-27. PubMed ID: 33301853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation of Receptor Binding Domain of SARS-CoV-2 S-Protein Influences on Binding to Immobilized DNA Aptamers.
    Grabovenko F; Nikiforova L; Yanenko B; Ulitin A; Loktyushov E; Zatsepin T; Zavyalova E; Zvereva M
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells.
    Bagdonaite I; Thompson AJ; Wang X; Søgaard M; Fougeroux C; Frank M; Diedrich JK; Yates JR; Salanti A; Vakhrushev SY; Paulson JC; Wandall HH
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33806155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana.
    Rattanapisit K; Shanmugaraj B; Manopwisedjaroen S; Purwono PB; Siriwattananon K; Khorattanakulchai N; Hanittinan O; Boonyayothin W; Thitithanyanont A; Smith DR; Phoolcharoen W
    Sci Rep; 2020 Oct; 10(1):17698. PubMed ID: 33077899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2.
    Xi CR; Di Fazio A; Nadvi NA; Patel K; Xiang MSW; Zhang HE; Deshpande C; Low JKK; Wang XT; Chen Y; McMillan CLD; Isaacs A; Osborne B; Vieira de Ribeiro AJ; McCaughan GW; Mackay JP; Church WB; Gorrell MD
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33218025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of SARS-CoV-2 surface glycoprotein fragment 319-640 in E. coli, and its refolding and purification.
    Fitzgerald GA; Komarov A; Kaznadzey A; Mazo I; Kireeva ML
    Protein Expr Purif; 2021 Jul; 183():105861. PubMed ID: 33667651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Protein Production from Stable CHO Cell Pools.
    Delafosse L; Lord-Dufour S; Pelletier A; Perret S; Burlacu A; Ouimet M; Cass B; Joubert S; Stuible M; Durocher Y
    Methods Mol Biol; 2024; 2810():99-121. PubMed ID: 38926275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter.
    Xie L; Yi K; Li Y
    Virology; 2021 Jun; 558():22-27. PubMed ID: 33711560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-depth characterization of protein N-glycosylation for a COVID-19 variant-design vaccine spike protein.
    Huang J; Hou S; An J; Zhou C
    Anal Bioanal Chem; 2023 Mar; 415(8):1455-1464. PubMed ID: 36698045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein.
    Pillay TS
    J Clin Pathol; 2020 Jul; 73(7):366-369. PubMed ID: 32376714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.